Myoglobin Market Trends

  • Report ID: 4269
  • Published Date: Aug 14, 2024
  • Report Format: PDF, PPT

Myoglobin Market Trends

Growth Drivers

  • Rise in Myositis Condition – Myositis is a rare condition of weak and aching muscles. Such condition gets worse over the time. The rising occurrence of myositis is fueling the demand of myoglobin. For instance, in the United States, between 51,000 to 76,000 people have myositis.
  • Growing Prevalence of Cardiovascular Diseases – Cardiovascular diseases are a group of diseases that affect your blood vessels and heart. A physical inactivity, unhealthy diet, excessive tobacco uses and harmful use of alcohol are the main risk factors associated with cardiovascular diseases. According to the data released by the World Health Organization (WHO), CVDs cause the deaths of around 17.9 million people each year.
  • Increase in Acute Myocardial Infraction - Acute myocardial infarction occurs when the coronary blood flow decreases, which results in cardiac ischemia. For instance, with prevalence reaching around 3 million people worldwide and more than 1 million deaths in the United States each year, acute myocardial infarctions are one of the most prevalent causes of death in the developed regions.
  • Escalating Numbers of Cardiac Surgeries – Cardiac surgeries are common to those people who have heart diseases or have had a heart attack, as well as those who are at high risk of having these problems. For instance, every year, approximately 510,000 open heart surgeries are performed worldwide.
  • Growing Healthcare Expenditure – As per the data released by the World Bank, the worldwide healthcare expenditures in 2019 increased to 9.83%.

Challenges

  • Lack of Skilled Professionals to Conduct Myoglobin Biomarker Tests
  • Lack of Awareness Regarding Myoglobin
  • Stringent Government Regulations About Clinical Trials

Myoglobin Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

4.1%

Base Year Market Size (2023)

USD 98.71 billion

Forecast Year Market Size (2036)

USD 166.43 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
 
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4269
  • Published Date: Aug 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of myoglobin is evaluated at USD 101.95 billion.

Myoglobin Market size was over USD 98.71 billion in 2023 and is projected to exceed USD 166.43 billion by 2036, growing at over 4.1% CAGR during the forecast period i.e., between 2024-2036. Rise in myositis condition, growing prevalence of cardiovascular diseases, increase in acute myocardial infarction, and escalating numbers of cardiac surgeries will propel the market growth.

North America industry is expected to dominate majority revenue share by 2036, backed by rise in launching of myoglobin reagents testing kits, growing prevalence of cardiovascular diseases, and boosted investment in research and development of novel biomarkers in the region.

The major players in the market are Abbott Diagnostics, Alere, Beckman Coulter, Biomerieux, Boditech Med, Ortho-Clinical Diagnostics, Randox Laboratories, Roche Diagnostics Corp, Siemens Healthcare Diagnostics, Singulex, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample